Corticosteroids

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

NeuroMetrix Reports 2009 Financial Results

Published February 10, 2010, 4:01 am, Business Wire via Yahoo! Finance

WALTHAM, Mass.----NeuroMetrix, Inc. , a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009.

Discover News | Full Story


Dementia: A Focused Review

Published February 9, 2010, 5:17 pm, Psychiatric Times

Dr Kalapatapu is a fellow in the department of addiction psychiatry at Columbia University, New York State Psychiatric Institute, New York. He completed a fellowship in geriatric psychiatry at the Mount Sinai School of Medicine in New York in July 2009. The author reports no conflicts of interest concerning the subject matter of this article and has declined the honorarium for this article.

Discover News | Full Story


Comment On Link Between HRT And Asthma

Published February 9, 2010, 3:19 am, Medical News Today

Leanne Metcalf, Director of Research at Asthma UK, says: 'There is now a large body of evidence suggesting a link between female hormones, including the use of HRT, the development of asthma and its severity. However this is the first large-scale and long-term study to suggest that it is oestrogen-only HRT which significantly increases the risk. 'It's still too early to say exactly how the ...

Discover News | Full Story


Doctors Need More Freedom Of Choice In Rescue Asthma Therapy

Published February 9, 2010, 3:18 am, Medical News Today

A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients. 100% of the doctors surveyed reported that some of their patients suffer "annoying" side-effects, such as hyperactivity and jitteriness with a similar and more commonly ...

Discover News | Full Story


Did saltpeter sabotage sex life? - Tue, 09 Feb 2010 PST

Published February 9, 2010, 12:14 am, The Spokesman-Review

Q. I’m a 28-year-old male, and I’ve never had much of a sex drive. I recently learned from a family member that my mother, believing it curbed sexual appetite, dosed my brother and me with a spoonful or two of saltpeter each day. I don’t know how long this went on, but I’m worried about what long-term effects chronic saltpeter consumption may have, sexual and otherwise.

Discover News | Full Story


Saltpeter curbs sex drive?

Published February 8, 2010, 7:17 pm, The News & Observer

Q. I'm a 28-year-old male, and I've never had much of a sex drive. I recently learned from a family member that my mother, believing it curbed sexual appetite, dosed my brother and me with a spoonful or two of saltpeter each day.

Discover News | Full Story


Herbals Not the Answer for Asthma, Study Shows

Published February 8, 2010, 1:29 pm, MedicineNet.com

Title: Herbals Not the Answer for Asthma, Study Shows Category: Health News Created: 2/5/2010 12:10:00 PM Last Editorial Review: 2/8/2010

Discover News | Full Story


People's Pharmacy: Is there a connection between saltpeter and low libido?

Published February 6, 2010, 7:09 pm, Seattle Times

People's Pharmacy answers questions about the connection between saltpeter and low libido; "sour stomach"; and steroids and cataracts.

Discover News | Full Story


Lux Biosciences Files For LUVENIQ™ Approval In US And Europe For Noninfectious Uveitis

Published February 6, 2010, 12:48 am, Medical News Today

Lux Biosciences, Inc. today announced its submission of simultaneous regulatory filings to both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking marketing approval for its investigational drug LUVENIQ™ (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye. Efficacy of LX211 in ...

Discover News | Full Story


Lux Bio seeks US & European marketing nod for oral voclosporin to treat non-infectious uveitis

Published February 5, 2010, 10:36 pm, PharmaBiz

Lux Biosciences, Inc. announced its submission of simultaneous regulatory filings to both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking marketing approval for its investigational drug Luveniq (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a